Company intelligence / Profile preview

RLS Group

Lake Zurich, Illinois, United States

Ownership: Private
Employees: ~350
Development stage: Other

Overview

RLS operates the only Joint Commission-accredited radiopharmacy network in the U.S., with commercial-scale distribution of PET and SPECT imaging agents, including proprietary and third-party radiopharmaceuticals; recent acquisition by Telix expands its manufacturing platform with integrated radiometal production.

Therapeutic areas: OncologyNeurologyCardiovascular
Modalities: RadiopharmaceuticalDiagnostic Imaging AgentTherapeutic Radiopharmaceutical
Industry: Biotech

Partnerships

Telix (parent company)ARTMSIsoTherapeuticsOptimal Tracers (within Telix Manufacturing Solutions network)

Beyond the preview

Go deeper on RLS Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RLS Group.

Explore the full profile